Category: GI Dynamics
JenaValve taps ex-AtriCure chief David Drachman to be its new CEO.
, Bioject Medical Technologies Inc.
, Echo Therapeutics Inc.
, Hill-Rom Holdings Inc.
, Integrity Applications
, U.S. Veterans Affairs Dept. (VA)
, GI Dynamics
Here's a look at some of the top funding stories for medical device companies this week.
Here's a look at some of the top Wall Street stories for medical device companies this week.
, Cardiovascular Systems Inc.
, Edwards Lifesciences
, Endo Health
, Hansen Medical Inc.
, Intuitive Surgical Inc.
, Johnson & Johnson
, Morgan Stanley
, Accuray Inc.
, GI Dynamics
GI Dynamics raises roughly $32 million via a private placement with foreign investors.
GI Dynamics (ASX:GID) said it raised about $31.7 million (A$34.3 million) in a private placement with a group of "sophisticated, professional and accredited investors" overseas.
GI Dynamics keeps knocking down global milestones, touting reimbursement new wins in Israel and the Netherlands.
Weight-loss devices maker GI Dynamics (ASX:GID) announced a couple of new wins in recent weeks, tallying new reimbursement coverage from healthcare officials in Israel and the Netherlands.
GI Dynamics' EndoBarrier weight loss and diabetes device, wins a reimbursement nod from German authorities.
GI Dynamics (ASX:GID) said it won a reimbursement nod in Germany for its flagship EndoBarrier weight loss and diabetes device.
Regulators in Switzerland and Germany take the 1st steps toward reimbursement for GI Dynamics' flagship EndoBarrier device to treat obesity and Type II diabetes.
GI Dynamics (ASX:GID) said Swiss and German regulators took the 1st steps toward reimbursement in those countries for its EndoBarrier weight loss and diabetes device.